Cover Image

TMAO Promotes NLRP3 Inflammasome Activation of Microglia Aggravating Neurological Injury in Ischemic Stroke Through FTO/IGF2BP2

Pengxin Ge,1,&ast; Huijie Duan,2,&ast; Chunrong Tao,3,&ast; Sensen Niu,4 Yiran Hu,5 Rui Duan,6 Aizong Shen,7 Yancai Sun,1 Wen Sun3 1Department of Pharmacy, Anhui Provincial Cancer Hospital, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Scien...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ge P (Author), Duan H (Author), Tao C (Author), Niu S (Author), Hu Y (Author), Duan R (Author), Shen A (Author), Sun Y (Author), Sun W (Author)
Format:	Book
Published:	Dove Medical Press, 2023-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Implication of genetic variants near <it>SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, FTO, TCF2</it>, <it>KCNQ1</it>, and <it>WFS1 </it>in Type 2 Diabetes in a Chinese population
by: Zhou Xianghai, et al.
Published: (2010)

Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: <it>PPARG2 (Pro12Ala)</it>, <it>IGF2BP2</it>, <it>TCF7L2 </it>and<it> FTO </it>variants confer a significant risk
by: Mehra Narinder K, et al.
Published: (2008)

Zmiany w stężeniach insulinopodobnych czynników wzrostu IGF-1 i IGF-2 i białek wiążących BP-2 i BP-3 w czasie leczenia ostrej białaczki limfoblastycznej
by: Maryna Krawczuk-Rybak, et al.
Published: (2004)

IGF2BP1, a New Target to Overcome Drug Resistance in Melanoma?
by: Yufeng Xi, et al.
Published: (2022)

Corylin inhibits LPS-induced inflammatory response and attenuates the activation of NLRP3 inflammasome in microglia
by: Ming-Yii Huang, et al.
Published: (2018)

Ouabain-mediated downregulation of ALKBH5 and IGF2BP2 inhibits the malignant progression of DLBCL
by: Yuxin Hong, et al.
Published: (2024)

Nrf2 Deficiency Exacerbates Parkinson’s Disease by Aggravating NLRP3 Inflammasome Activation in MPTP-Induced Mouse Models and LPS-Induced BV2 Cells
by: Lu R, et al.
Published: (2024)

LINC01001 Promotes Progression of Crizotinib-Resistant NSCLC by Modulating IGF2BP2/MYC Axis
by: Meiling Zhang, et al.
Published: (2021)

Edaravone Plays Protective Effects on LPS-Induced Microglia by Switching M1/M2 Phenotypes and Regulating NLRP3 Inflammasome Activation
by: Jiping Li, et al.
Published: (2021)

IGF2BP3 (IMP3) expression in angiosarcoma, epithelioid hemangioendothelioma, and benign vascular lesions
by: Misuzu Okabayshi, et al.
Published: (2020)

Effect of urea and tmao on lipid bilayers
by: Valerio J., et al.
Published: (2017)

Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in hematological diseases
by: Shuangping Ma, et al.
Published: (2024)

Emerging trends and hot spots of NLRP3 inflammasome in neurological diseases: A bibliometric analysis
by: Xiaoyan Yu, et al.
Published: (2022)

The role of NLRP3 inflammasome in the pathogenesis of rheumatic disease
by: Ruixue Kong, et al.
Published: (2022)

Differential expression and clinical significance of IGF2BP3 in peritoneal dialysate of patients with varying duration of peritoneal dialysis
by: Xiaoqi Shao, et al.
Published: (2024)

The role of NLRP3 inflammasome in type 2 inflammation related diseases
by: Shenming Xu, et al.
Published: (2024)

Artemisia Extract Suppresses NLRP3 and AIM2 Inflammasome Activation by Inhibition of ASC Phosphorylation
by: Su-Bin Kwak, et al.
Published: (2018)

The Flavonoid Agathisflavone Directs Brain Microglia/Macrophages to a Neuroprotective Anti-Inflammatory and Antioxidant State via Regulation of NLRP3 Inflammasome
by: Balbino Lino dos Santos, et al.
Published: (2023)

Association of TMAO levels with indicators of ulcerative colitis activity
by: Yelena Laryushina, et al.
Published: (2025)

Modified Citrus Pectin Alleviates Cerebral Ischemia/Reperfusion Injury by Inhibiting NLRP3 Inflammasome Activation via TLR4/NF-&kgreen;B Signaling Pathway in Microglia
by: Cui Y, et al.
Published: (2022)

METTL3 and IGF2BP1-mediated m6A modification of ZHX2 promotes tumor property of renal cell carcinoma
by: Bangming Xiao, et al.
Published: (2024)

Activation of Platelet NLRP3 Inflammasome in Crohn's Disease
by: Ge Zhang, et al.
Published: (2021)

Long-Term Alcohol Exposure Aggravates Ischemic Stroke-Induced Damage by Promoting Pericyte NLRP3 Inflammasome Activation via Pre-Activating the TLR4/NF-κB Pathway in Rats
by: Wang K, et al.
Published: (2024)

Ligustrazine inhibits inflammatory response of human endometrial stromal cells through the STAT3/IGF2BP1/RELA axis
by: Ying Feng, et al.
Published: (2023)

IGF2BP3 promotes glutamine metabolism of endometriosis by interacting with UCA1 to enhances the mRNA stability of GLS1
by: Honglin Wang, et al.
Published: (2024)

Neurodegenerative Disease and the NLRP3 Inflammasome
by: Jonathan A. Holbrook, et al.
Published: (2021)

NLRP3 inflammasome in metabolic syndrome
by: Fang Wang, et al.
Published: (2021)

Spotlight on the NLRP3 inflammasome pathway
by: Groslambert M, et al.
Published: (2018)

The role of the NLRP3 inflammasome in gout
by: Sarah R Kingsbury, et al.
Published: (2011)

RNA m6A reader IMP2/IGF2BP2 promotes pancreatic β-cell proliferation and insulin secretion by enhancing PDX1 expression
by: Laura Regué, et al.
Published: (2021)

NLRP3 Inflammasome and Pyroptosis in Liver Pathophysiology: The Emerging Relevance of Nrf2 Inducers
by: Laura Hurtado-Navarro, et al.
Published: (2022)

M1 Microglia-Derived Exosomes Promote A1 Astrocyte Activation and Aggravate Ischemic Injury via circSTRN3/miR-331-5p/MAVS/NF-κB Pathway
by: Li Z, et al.
Published: (2024)

Punicalagin Attenuates LPS-Induced Inflammation and ROS Production in Microglia by Inhibiting the MAPK/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation
by: Lo J, et al.
Published: (2022)

Amentoflavone Affects Epileptogenesis and Exerts Neuroprotective Effects by Inhibiting NLRP3 Inflammasome
by: Shikuo Rong, et al.
Published: (2019)

The NLRP3 Inflammasome as a Novel Therapeutic Target for Cardiac Fibrosis
by: Fan J, et al.
Published: (2022)

Long noncoding RNA LIPH-4 promotes esophageal squamous cell carcinoma progression by regulating the miR-216b/IGF2BP2 axis
by: Yuhang Xiao, et al.
Published: (2022)

Role of NLRP3 Inflammasome in Lupus Nephritis and Therapeutic Targeting by Phytochemicals
by: Dantong Wu, et al.
Published: (2021)

NLRP3 inflammasome activation by Paracoccidioides brasiliensis.
by: Aldo Henrique Tavares, et al.
Published: (2013)

The role of NLRP3 inflammasome in hepatocellular carcinoma
by: Huijie Zhao, et al.
Published: (2023)

Acute Lung Injury and the NLRP3 Inflammasome
by: Gu W, et al.
Published: (2024)